DRR:ASXDeterra Royalties Ltd Analysis
Data as of 2026-06-13 - not real-time
A$4.49
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The 20‑day SMA sits comfortably above the 50‑day and 200‑day averages, confirming a bullish alignment, while the RSI hovers in the mid‑50s, suggesting neutral momentum. Volume is on an upward trend and the price remains above the identified support level, though the MACD histogram is slightly negative, hinting at short‑term caution.
Fundamental backdrop: The company boasts exceptionally high gross and operating margins, a solid dividend yield that ranks among the highest in its peer group, and a DCF‑derived fair value that sits above the current market price, indicating modest upside potential. With a diversified royalty portfolio across multiple commodities and geographies, the earnings base appears resilient, and the payout ratio suggests that the dividend is likely sustainable.
Fundamental backdrop: The company boasts exceptionally high gross and operating margins, a solid dividend yield that ranks among the highest in its peer group, and a DCF‑derived fair value that sits above the current market price, indicating modest upside potential. With a diversified royalty portfolio across multiple commodities and geographies, the earnings base appears resilient, and the payout ratio suggests that the dividend is likely sustainable.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price trading above short‑term support
- increasing volume reinforcing bullish bias
- MACD histogram still negative, cautioning against rapid entry
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- undervalued relative to DCF fair value
- robust dividend yield supporting total return
- steady revenue growth and high operating margins
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- diversified royalty assets across commodities and regions
- sustainable payout ratio with strong cash flow generation
- low beta indicating limited market volatility exposure
Key Metrics & Analysis
Financial Health
Revenue Growth8.10%
Profit Margin65.67%
P/E Ratio13.2
ROE149.19%
ROA36.60%
Debt/Equity112.65
P/B Ratio17.1
Op. Cash FlowA$172.6M
Free Cash FlowA$151.6M
Technical Analysis
TrendBullish
RSI56.1
SupportA$4.26
ResistanceA$4.74
MA 20A$4.48
MA 50A$4.32
MA 200A$4.18
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Fair ValueA$5.07
Target PriceA$4.65
Upside/Downside3.47%
GradeUndervalued
TypeBlend
Dividend Yield5.52%
Risk Assessment
Beta0.53
Volatility19.61%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.